Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
Vincent Wai‐Sun Wong, Leon A. Adams, Victor de Lédinghen, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 8, pp. 461-478
Closed Access | Times Cited: 527

Showing 1-25 of 527 citing articles:

Non-alcoholic fatty liver disease
Elizabeth E. Powell, Vincent Wai‐Sun Wong, Mary E. Rinella
The Lancet (2021) Vol. 397, Iss. 10290, pp. 2212-2224
Closed Access | Times Cited: 1810
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Mohammed Eslam, Shiv Kumar Sarin, Vincent Wai‐Sun Wong, et al.
Hepatology International (2020) Vol. 14, Iss. 6, pp. 889-919
Open Access | Times Cited: 637
Changing epidemiology, global trends and implications for outcomes of NAFLD
Vincent Wai‐Sun Wong, Mattias Ekstedt, Grace Lai‐Hung Wong, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 842-852
Open Access | Times Cited: 280
Ferroptosis Affects the Progression of Nonalcoholic Steatohepatitis via the Modulation of Lipid Peroxidation–Mediated Cell Death in Mice
Jing Qi, Jong-Won Kim, Zixiong Zhou, et al.
American Journal Of Pathology (2019) Vol. 190, Iss. 1, pp. 68-81
Open Access | Times Cited: 252
Non-alcoholic fatty liver disease: A patient guideline
Sven Francque, Giulio Marchesini, Achim Kautz, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100322-100322
Open Access | Times Cited: 205
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
Jianghua Zhou, Jingjing Cai, Zhi‐Gang She, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 11, pp. 1307-1326
Open Access | Times Cited: 204
Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population
Helene Gellert‐Kristensen, Tom G. Richardson, George Davey Smith, et al.
Hepatology (2020) Vol. 72, Iss. 3, pp. 845-856
Open Access | Times Cited: 187
Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease
Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong, Jean Woo, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 10, pp. 2161-2171.e5
Open Access | Times Cited: 168
Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease
Evangelia Makri, A. Goulas, Stergios A. Pοlyzos
Archives of Medical Research (2020) Vol. 52, Iss. 1, pp. 25-37
Closed Access | Times Cited: 165
Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease
Vincent Wai‐Sun Wong, Marie Irlès, Grace Lai‐Hung Wong, et al.
Gut (2019) Vol. 68, Iss. 11, pp. 2057-2064
Closed Access | Times Cited: 147
Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease
Raghu Ramanathan, Ahmad H. Ali, Jamal A. Ibdah
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7280-7280
Open Access | Times Cited: 101
Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index–related parameters
Yan Xue, Jiahui Xu, Man Li, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 100
Risk assessment with gut microbiome and metabolite markers in NAFLD development
Howell Leung, Xiaoxue Long, Yueqiong Ni, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 648
Open Access | Times Cited: 79
Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations
Yueqiong Ni, Lingling Qian, Sara Leal Siliceo, et al.
Cell Metabolism (2023) Vol. 35, Iss. 9, pp. 1530-1547.e8
Open Access | Times Cited: 73
Noninvasive Assessment of Liver Fibrosis in NAFLD
Arun J. Sanyal, Laurent Castéra, Vincent Wai‐Sun Wong
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2026-2039
Closed Access | Times Cited: 70
From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease
Mary E. Rinella, Silvia Sookoian
Journal of Lipid Research (2023) Vol. 65, Iss. 1, pp. 100485-100485
Open Access | Times Cited: 68
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
Huapeng Lin, Hye Won Lee, Terry Cheuk‐Fung Yip, et al.
JAMA (2024) Vol. 331, Iss. 15, pp. 1287-1287
Open Access | Times Cited: 59
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
Yao Yu, Jingjing Cai, Zhi‐Gang She, et al.
Advanced Science (2018) Vol. 6, Iss. 4
Open Access | Times Cited: 149
Relationship between Heart Disease and Liver Disease: A Two-Way Street
Hamza El Hadi, Angelo Di Vincenzo, Roberto Vettor, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 567-567
Open Access | Times Cited: 127
Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans
Luca Maccioni, Bei Gao, Sophie Leclercq, et al.
Gut Microbes (2020) Vol. 12, Iss. 1, pp. 1782157-1782157
Open Access | Times Cited: 124
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia
Miquel Serra‐Burriel, Isabel Graupera, Pere Torán‐Monserrat, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 6, pp. 1141-1151
Open Access | Times Cited: 121
Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
Hannah K. Drescher, Sabine Weiskirchen, Ralf Weiskirchen
Cells (2019) Vol. 8, Iss. 8, pp. 845-845
Open Access | Times Cited: 120
Biological Role of Unsaturated Fatty Acid Desaturases in Health and Disease
Aleksandra Czumaj, Tomasz Śledziński
Nutrients (2020) Vol. 12, Iss. 2, pp. 356-356
Open Access | Times Cited: 107
Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
Marion Régnier, Arnaud Polizzi, Sarra Smati, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 107
Application of transient elastography in nonalcoholic fatty liver disease
Xinrong Zhang, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong
Clinical and Molecular Hepatology (2019) Vol. 26, Iss. 2, pp. 128-141
Open Access | Times Cited: 102
Page 1 - Next Page

Scroll to top